超声引导高强度聚焦超声治疗子宫肌瘤与子宫腺肌病的安全性和有效性
研究纳入1807例子宫肌瘤(928例)和子宫腺肌病(889例)患者,采用海扶JC型聚焦超声肿瘤治疗系统(换能器频率0.8 MHz、功率300-400 W/cm²)在实时超声引导下(2.5-5.0 MHz成像探头)行超声引导高强度聚焦超声消融。治疗后3、6、12个月症状严重程度评分、健康相关生活质量评分及病灶体积缩小均显示良好效果,并发症发生率4.6%(84/1807),经支持治疗均缓解且无永久性不良影响。
要点
- 治疗后3、6、12个月症状严重程度评分、健康相关生活质量评分及肌瘤和腺肌病病灶体积缩小均显示良好效果。
- 并发症发生率为4.6%(84/1807),经支持治疗均缓解,无永久性不良影响。
- 作者认为超声引导高强度聚焦超声是治疗子宫肌瘤和子宫腺肌病的有效、无创方式,并发症可控。
核心结论
- 超声引导高强度聚焦超声是治疗子宫肌瘤和子宫腺肌病的有效、无创方式,并发症可控。
研究设计与样本
- 研究共纳入1807例患者,其中子宫肌瘤928例、子宫腺肌病889例。
- 采用海扶JC型聚焦超声肿瘤治疗系统,换能器频率0.8 MHz、功率300-400 W/cm²。
- 在实时超声引导下进行,成像探头频率2.5-5.0 MHz。
- 采用子宫肌瘤症状与生活质量问卷评估症状严重程度评分和健康相关生活质量评分。
诊断标准与关键数值
- 治疗后3、6、12个月症状严重程度评分、健康相关生活质量评分及子宫腺肌病和肌瘤体积缩小均显示良好效果。
临床应用与阅片要点
- 作者认为超声引导高强度聚焦超声是治疗子宫肌瘤和子宫腺肌病的有效、无创方式,并发症可控。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The objective of this study was to assess the tolerability and efficacy of ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation using a Haifu JC Focused Ultrasound Tumor Therapeutic System (operating transducer frequency: 0.8 MHz, 300-400 W/cm2) under real-time ultrasound guidance (2.5- to 5.0-MHz imaging probe) for uterine fibroids and adenomyosis in 1807 patients (928 with fibroids and 889 with adenomyosis). Volume change and clinical symptom improvement after treatment were evaluated based on symptom severity scores and health-related quality of life scores using the Uterine Fibroid Symptom and Quality of Life questionnaires. At 3, 6 and 12 mo after treatment, symptom severity scores and health-related quality of life scores and reductions in volumes of uterine adenomyosis and fibroids all revealed good effects. The complication rate was 4.6% (84/1807). With supportive care, all complications resolved without any permanent adverse effects. Thus, USgHIFU is an effective, non-invasive modality for treating uterine fibroids and adenomyosis with manageable complications.
引用
- Lee JS, Hong GY, Lee KH, et al. Safety and Efficacy of Ultrasound-Guided High-Intensity Focused Ultrasound Treatment for Uterine Fibroids and Adenomyosis. Ultrasound Med Biol. 2019. PMID: 31563479. doi:10.1016/j.ultrasmedbio.2019.08.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。